| # | Drug | Count |
|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 62 |
| 1 | RIVAROXABAN | 36 |
| 2 | ASPIRIN | 29 |
| 3 | ASPIRIN 325 MG | 29 |
| 4 | ASPIRIN 81 MG | 29 |
| 5 | CLOPIDOGREL | 20 |
| 6 | EMICIZUMAB | 19 |
| 7 | METOPROLOL | 17 |
| 8 | METOPROLOL TARTRATE | 17 |
| 9 | BISOPROLOL FUMARATE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARSTACIMAB-HNCQ | 1 | 0.0097 |
| 1 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 62 | 0.0075 |
| 2 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 8 | 0.0071 |
| 3 | GLYCERINE | 2 | 0.0062 |
| 4 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 3 | 0.0053 |
| 5 | ANTIHEMOPHILIC FACTOR HUMAN | 4 | 0.0029 |
| 6 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 10 | 0.0026 |
| 7 | AMINOCAPROIC ACID | 2 | 0.0025 |
| 8 | CALCIUM ANTACID | 1 | 0.0023 |
| 9 | GADOXETATE DISODIUM | 1 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 44 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 29 |
| 3 | Benzodiazepine [EPC] | 24 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 24 |
| 5 | Corticosteroid [EPC] | 21 |
| 6 | Loop Diuretic [EPC] | 14 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 14 |
| 8 | Osmotic Laxative [EPC] | 13 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 2 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 3 | Antifibrinolytic Agent [EPC] | 3 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 5 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 6 | Muscle Relaxant [EPC] | 11 | 0.0002 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Factor Xa Inhibitor [EPC] | 44 | 0.0002 |